Fig. 1From: A randomised controlled trial to assess the antithrombotic effects of aspirin in type 1 diabetes: role of dosing and glycaemic controlDesign of the study. C3, complement component 3; HbA1c, glycated haemoglobin A1c; LTA, light transmittance aggregometry; OD, once dailyBack to article page